In Search For Profits

Monday, December 15, 2003


Flamel, nano-encapsulation for drug delivery

Josh Wolfe, Co-Founder of Lux Capital and editor of the Forbes Nanotech Report, is recommending Flamel Technologies calling attention to the company's improved cash position.

It seems Merrill Lynch expects a 30% run on this stock.

Check it out!


Home | Archive
Past articles
































































































































































blog*spot
get rid of this ad | advertise here